Abstract
The ubiquitin/proteasome-dependent proteolytic pathway is an attractive target for therapeutics because of its critical involvement in cell cycle progression and antigen presentation. However, dissection of the pathway and development of modulators are hampered by the complexity of the system and the lack of easily detectable authentic substrates. We have developed a convenient reporter system by producing N-end rule and ubiquitin fusion degradation (UFD)-targeted green fluorescent proteins that allow quantification of ubiquitin/proteasome-dependent proteolysis in living cells. Accumulation of these reporters serves as an early predictor of G2/M arrest and apoptosis in cells treated with proteasome inhibitors. Comparison of reporter accumulation and cleavage of fluorogenic substrates demonstrates that the rate-limiting chymotrypsin-like activity of the proteasome can be substantially curtailed without significant effect on ubiquitin-dependent proteolysis. These reporters provide a new powerful tool for elucidation of the ubiquitin/proteasome pathway and for high throughput screening of compounds that selectively modify proteolysis in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
214,86 € per year
only 17,91 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425–479 (1998).
Finley, D. Ozkaynak, E. & Varshavsky, A. The yeast polyubiquitin gene is essential for resistance to high temperatures, starvation, and other stresses. Cell 48, 1035–1046 (1987).
Heinemeyer, W. Kleinschmidt, J.A. Saidowsky, J. Escher, C. & Wolf, D.H. Proteinase yscE, the yeast proteasome/multicatalytic–multifunctional proteinase: mutants unravel its function in stress-induced proteolysis and uncover its necessity for cell survival. EMBO J. 10 , 555–562 (1991).
Rock, K.L. & Goldberg, A.L. Degradation of cell proteins and the generation of MHC class I- presented peptides. Annu. Rev. Immunol. 17, 739–779 ( 1999).
Schwartz, A.L. & Ciechanover, A. The ubiquitin–proteasome pathway and pathogenesis of human diseases. Annu. Rev. Med. 50, 57–74 (1999).
Bogyo, M. Gaczynska, M. & Ploegh, H.L. Proteasome inhibitors and antigen presentation. Biopolymers 43, 269–280 (1997).
Lee, D.H. & Goldberg, A.L. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8, 397–403 (1998).
Teicher, B.A., Ara, G., Herbst, R., Palombella, V.J. & Adams, J. The proteasome inhibitor PS-341 in cancer therapy. Clin. Cancer Res. 5, 2638–2645 (1999).
Adams, J., et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 59, 2615–2622 (1999).
Meng, L., Kwok, B.H., Sin, N. & Crews, C.M. Eponemycin exerts its antitumor effect through the inhibition of proteasome function. Cancer Res. 59, 2798–2801 (1999).
Meng, L. et al. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc. Natl. Acad. Sci. USA 96, 10403–10408 (1999).
Bochtler, M., Ditzel, L., Groll, M., Hartmann, C. & Huber, R. The proteasome. Annu. Rev. Biophys. Biomol. Struct. 28, 295–317 ( 1999).
Laney, J. & Hochstrasser, M. Substrate targeting in the ubiquitin system. Cell 97, 427– 430 (1999).
Dick, T.P. et al. Contribution of proteasomal β-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J. Biol. Chem. 273, 25637–25646 (1998).
Kisselev, A.F., Akopian, T.N., Castillo, V. & Goldberg, A.L. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite–chew mechanism for protein breakdown. Mol. Cell 4, 395–402 (1999).
Dick, T.P. et al. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86, 253– 262 (1996).
Bachmair, A., Finley, D. & Varshavsky, A. In vivo half-life of a protein is a function of its amino-terminal residue. Science 234, 179 –186 (1986).
Johnson, E.S., Ma, P.C., Ota, I.M. & Varshavsky, A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 270, 17442–17456 ( 1995).
Gonda, D.K. et al. Universality and structure of the N-end rule. J. Biol. Chem. 264, 16700–16712 ( 1989).
Falnes, P.O. & Olsnes, S. Modulation of the intracellular stability and toxicity of diphtheria toxin through degradation by the N-end rule pathway. EMBO J. 17, 615–625 (1998).
Jensen, T.J. et al. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83, 129– 135 (1995).
Bogyo, M. et al. Covalent modification of the active site threonine of proteasomal β-subunits and the Escherichia coli homolog HslV by a new class of inhibitors. Proc. Natl. Acad. Sci. USA 94, 6629– 6634 (1997).
Bogyo, M., Shin, S., McMaster, J.S. & Ploegh, H.L. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. Chem. Biol. 5, 307– 320 (1998).
Andre, P. et al. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc. Natl. Acad. Sci. USA 95 , 13120–13124 (1998).
Schmidtke, G. et al. How an inhibitor of the HIV-I protease modulates proteasome activity. J. Biol. Chem. 274, 35734– 35740 (1999).
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W. & Prasher, D.C. Green fluorescent protein as a marker for gene expression. Science 263, 802–805 (1994).
Suzuki, T. & Varshavsky, A. Degradation signals in lysine–asparagine sequence space. EMBO J. 18, 6017– 6026 (1999).
Lee, D.H. & Goldberg, A.L. Proteasome inhibitors cause induction of heat shock proteins and trehalose, which together confer thermotolerance in Saccharomyces cerevisiae. Mol. Cell. Biol. 18, 30–38 (1998).
Orlowski, R.Z. The role of the ubiquitin–proteasome pathway in apoptosis. Cell Death Differ. 6, 303–313 (1999).
Gaczynska, M., Rock, K.L. & Goldberg, A.L. γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365, 264–267 (1993).
Nussbaum, A.K. et al. Cleavage motifs of the yeast 20S proteasome β-subunits deduced from digests of enolase 1. Proc. Natl. Acad. Sci. USA 95, 12504–12509 (1998).
Acknowledgements
We thank Hidde Ploegh and Benedikt Kessler for providing the peptide-vinyl sulfones, Bo Öberg for the ritonavir, Stefan Jentsch for the Ub-Pro-βGal plasmid, and Anatoly Sharipo and Teresa Frisan for helpful discussions. This work was supported by grants awarded by the Swedish Cancer Society, the Swedish Foundation of Strategy Research, and the Hedlund Foundation, Stockholm, Sweden. N.P.D. is supported by a postdoctoral fellowship awarded by the European Commission Training and Mobility Program on “The central role of the ubiquitin-proteasome system in regulatory processes involved in immunological, inflammatory, endocrinological and malignant disorders,” contract no. ERBFMRXCT960026.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dantuma, N., Lindsten, K., Glas, R. et al. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat Biotechnol 18, 538–543 (2000). https://doi.org/10.1038/75406
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/75406


